Aktienanalyse zu Butterfly Network, Inc. (BFLY)BFLYButterfly Network, Inc.

Butterfly Network, Inc. is a digital health business offering care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. Its ultrasound devices can perform whole-body imaging with a single handheld probe. Its Ultrasound-on-Chip makes ultrasound accessible outside of healthcare institutions, while its software is intended to make the product fully integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and any hospital computer system. It markets and sells the Butterfly system, which includes probes, related accessories, and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and its e-commerce channel. It licenses its Ultrasound-on-Chip semiconductor platform for co-development of novel technologies through its Embedded program. Its products consist of iQ3, iQ+, iQ+ Bladder, and Compass AI software. It operates in the Healthcare sector (X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPA industry).

Butterfly Network Inc (BFLY) appears to be a good buy right now, trading at $8.25 with a potential upside of 31.57% to the analyst consensus target price of $10.71. The stock has shown significant year-to-date growth of 120% and a remarkable 258.70% increase over the past year, reflecting strong market interest. However, the company is currently facing a net loss of $74.8 million, which poses a risk to its financial stability.